M Ventures Performance Materials Fund Sven Harmsen Investment - - PowerPoint PPT Presentation

MERCK VENTURES

B.V. Amsterdam, Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany

Sven Harmsen Investment Director Performance Materials Fund

M Ventures

In 1887, Merck KGaA, Darmstadt, Germany

• pened its own office

in New York, which gave rise to the subsidiary Merck & Co., Inc., Kenilworth, NJ three years later. As a result of World War I, this subsidiary was expropriated in 1917 and has been an independent company ever since. Merck KGaA, Darmstadt, Germany – the original holds the global rights to the Merck name and brand. Exceptions are Canada and the United States, where we operate as EMD Serono, MilliporeSigma and EMD Performance Materials.

THE ORIGINAL THE ORIGINAL THE ORIGINAL THE ORIGINAL

What we do

Life Science Performance Materials Healthcare

A wide range of specialty chemicals, such as liquid crystals for displays, effect pigments for coatings and cosmetics, or high-tech materials for the electronics industry. Innovative tools and laboratory supplies for the life science industry that make research and biotech production easier, faster and more successful. Prescription medicines to treat, for example, cancer, multiple sclerosis and infertility, over-the-counter pharmaceuticals for everyday health protection or to provide fast relief of colds and pain, as well as innovations in the areas of allergies and biosimilars.

Merck Ventures mission Providing a window on innovation “Merck Ventures drives innovation and backs entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck’s current and future businesses” Outside – In Venture investments in external innovation Inside – Out Creation of new businesses around Merck technologies

Primary financing mechanisms

From MS Ventures to Merck Ventures The expanded Merck Venture Fund

Strategic Investment Fund Strategic Investment Fund Sector dedicated teams Investment professionals Sector dedicated teams Investment professionals Fund organization Fund organization Merck Ventures

Seed investments & Company creation Direct investments in syndicated deals Merck Spin-offs Israel Incubator

Portfolio company overview by Fund and Therapeutic Area 20 Active companies in HealthCare; 2 investments in New Businesses

Health Care Oncology Health Care Neurology Health Care Fertility Health Care

• Disc. Tech

Health Care Autoimmune

Active Exit

New Businesses

Merck Ventures the corporate venture capital arm of Merck Four dedicated funds to add another tool to capture innovation for the three high-tech businesses

€ 150M

Investments in the next generation of drugs

• Biologics and small-

molecules

• Investment focus:

Oncology, Immunology & Immuno-Oncology

• Finding novel solutions

for patients

€ 50M

Investments in the life science business

• Next generation tools

and services for biotech research & production

• Tools and laboratory

supply for the academic research and industrial testing

€ 50M

Investments in materials and applications

• Materials for and

applications of organic electronics

• New applications of LC’s
• Pigments and related

functional materials

• High-tech materials for

integrated circuits, esp. advanced packaging

€ 50M

Investments in new business fields

• To essentially establish a

forth business pillar for the Merck Group

• Very broad mandate
• Anything in the fields of

digital, agriculture, food and beyond

Life Science Performance Materials Healthcare New Businesses

Merck Ventures – Performance Materials R&D priorities Technology hot spots and search fields by BU

New non-display applications for LCs, e.g. − Smart Antennas − Light Guides and Waveplates − Smart Vizor technologies Holography Technologies enabling flexible LC displays Technologies where materials are the enabler of further miniaturization Focus: Advanced Packaging − Thermal interface mat. − Mat. for embedded components − Surface modification − Low shrinkage mat. New electrode- and emitter materials for OLEDs Cadmium-free quantum dots and applications thereof Materials for µ-LED displays Improved perovskite SC & acceptor materials for OPV Hybrid Electronics and Electronics packaging

Integrated Circuit Materials Display Materials Advanced Technologies

Functional materials for cosmetics, food, pharma Anti-aging 3D printing (additive manufacturing)

Pigments & Functional Materials

Miniaturization of Electronics End of “Moore’s Law” requires new solutions for further miniaturization based

• n new materials

Internet of things 50 billion connected devices by 2020 require new, powerful materials

• mitting rare earth

elements Wearables & flexible electronics Trend of self-

• ptimization spurs

demand for healthcare and fitness devices enabled by flexible electronics Beauty & anti-aging Cosmetics growth in anti-aging segment is expected to continue with increasingly aging society

Trends significantly influencing the materials business in the next 3-5 years What does Merck Ventures hold for Merck’s future?

New visual environments Technologies enabling flexible and transparent displays as well as VR & AR devices

MERCK VENTURES

B.V., Amsterdam, the Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany